Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
UDR, Inc. ( UDR - Analyst Report ) , a real estate investment trust (REIT), reported third quarter 2012 FFO (funds from operations) of $86.5 million or 33 cents per share, compared with 73.0 million or 32 cents in the year-earlier quarter. Reported FFO per share was in line with the Zacks Consensus Estimate.
Total revenues during the quarter were $181.8 million compared with $163.9 million in the prior-year quarter.
Same-store occupancy remained relatively high at 95.8% during the quarter. Same-store revenues and net operating income increased 5.5% and 6.4% respectively, during the reported quarter compared to the year-ago quarter, to levels of $146.9 million and $99.1 million respectively.
During the reported quarter, UDR started construction on its Beach Walk development in Huntington Beach, California. Before construction, the company acquired the remaining 10% stake in Beach Walk from its former joint venture partner.
The community consists of 173 homes and has an estimated cost of $50.7 million. Additionally, the company acquired a land parcel in Santa Monica, California for $10.3 million through a joint venture.
Subsequent to the end of the quarter, UDR exchanged its ownership stake in four operating communities and two land parcels in the UDR-MetLife I joint venture, (along with $10 million in cash), with an increase in its stake in the A-quality operating community - The Olivian.
At closing, the company will own 50% of The Olivian, which will be a part of the UDR/MetLife II joint venture. The four operating communities and two land parcels for which UDR entered into arrangements to exchange have a combined debt of $134.7 million with a weighted average interest rate of 3.5% and a term of 7 years. The Olivian's debt stood at $63.4 million with an interest of 4.5% and a term of 7 years
At the end of the quarter, the company’s liquidity amounted to $1.1 billion through a combination of cash and undrawn capacity on its credit facilities. This amount is likely to meet UDR’s immediate capital needs for debt maturities, development and redevelopment activities.
As of September 30, 2012, UDR had total debt of $3.3 billion and a fixed charge coverage ratio of 2.9x. UDR ended the quarter with 89% fixed-rated debt at a total blended interest rate of 4.5% and a weighted average debt maturity of 4.8 years.
UDR currently retains a Zacks #2 Rank, which translates into a short-term Buy rating. We maintain our long-term Neutral recommendation on the stock. One of its competitors, Equity Residential ( EQR - Analyst Report ) also currently retains a Zacks #2 Rank.
Note: Fund from operations, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income.
Read the full Analyst Report on UDR
Read the full Analyst Report on EQR